ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis
ESR1 突变在接受内分泌治疗的乳腺癌新诊断的转移性和局部区域复发病例中很常见，且预后较差。
期刊:Breast Cancer Research
影响因子:5.6
doi:10.1186/s13058-020-1246-5
Zundelevich, Adi; Dadiani, Maya; Kahana-Edwin, Smadar; Itay, Amit; Sella, Tal; Gadot, Moran; Cesarkas, Karen; Farage-Barhom, Sarit; Saar, Efrat Glick; Eyal, Eran; Kol, Nitzan; Pavlovski, Anya; Balint-Lahat, Nora; Dick-Necula, Daniela; Barshack, Iris; Kaufman, Bella; Gal-Yam, Einav Nili
